Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 2Neoplasms 1Liver Neoplasms 1Hypertension, Portal 1Gallbladder Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 8Fluorouracil 5Cisplatin 5Leucovorin 4Oxaliplatin 3becatecarin 2Capecitabine 2seribantumab 1sargramostim 1pembrolizumab 1pazopanib 1motexafin lutetium 1ixabepilone 1irinotecan sucrosofate 1incomplete Freund's adjuvant 1durvalumab 1devimistat 1cediranib 1Trastuzumab 1Sorafenib 1Radiosurgery 1Psychiatric Rehabilitation 1Palonosetron 1Observation 1Liver Transplantation 1Folfox protocol 1Escitalopram 1Erlotinib Hydrochloride 1Carboplatin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Gallbladder Neoplasms × Liver Transplantation × Clear all
NCT01151761 2016-07-29

Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

Stanford University

Phase 2 Terminated
2 enrolled 9 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡